The lack of attention by mainstream medicine to the problems of overweight or obese patients have contributed to the burgeoning diet industry.
As obesity is increasingly being recognized as the underlying cause of many a disease, healthcare plans have changed their approach to the condition, especially folowing a provision within the Affordable Care Act. Insurers are now mandated to cover nutrition and obesity screening for their enrollees.
This has created a tremendous opportunity for diet clinics and resulted in an industry of sorts, which sometimes uses as yet unproven treatments like vitamin injections or dietary supplements that may not have been validated. The lack of attention by mainstream medicine to the problems of overweight or obese patients may have contributed to the burgeoning diet industry, says an article in The New York Times.
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More